Ellevest, Inc. Genmab A/S Transaction History

Ellevest, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$37.4 - $42.94 $9,200 - $10,563	-246 Reduced 4.2%	5,609 $213,000
Q1 2023 May 04, 2023	SELL	$34.88 - $43.22 $24,869 - $30,815	-713 Reduced 10.86%	5,855 $221,000
Q4 2022 Feb 03, 2023	BUY	$33.8 - $47.06 $15,581 - $21,694	461 Added 7.55%	6,568 $278,000
Q3 2022 Nov 02, 2022	BUY	$31.52 - $373.61 $1,229 - $14,570	39 Added 0.64%	6,107 $196,000
Q2 2022 Jul 18, 2022	SELL	$26.83 - $38.57 $38,849 - $55,849	-1,448 Reduced 19.27%	6,068 $197,000
Q1 2022 Apr 19, 2022	BUY	$30.95 - $39.68 $40,575 - $52,020	1,311 Added 21.13%	7,516 $272,000
Q4 2021 Jan 24, 2022	SELL	$35.87 - $47.12 $4,483 - $5,890	-125 Reduced 1.97%	6,205 $245,000
Q3 2021 Oct 19, 2021	BUY	$41.55 - $48.72 $27,672 - $32,447	666 Added 11.76%	6,330 $277,000
Q2 2021 Jul 13, 2021	BUY	$32.88 - $44.57 $35,806 - $48,536	1,089 Added 23.8%	5,664 $231,000
Q1 2021 May 03, 2021	BUY	$30.92 - $44.4 $48,791 - $70,063	1,578 Added 52.65%	4,575 $150,000
Q4 2020 Feb 04, 2021	BUY	$33.66 - $40.76 $49,951 - $60,487	1,484 Added 98.08%	2,997 $122,000
Q3 2020 Oct 26, 2020	BUY	$33.07 - $38.68 $41,370 - $48,388	1,251 Added 477.48%	1,513 $55,000
Q2 2020 Jul 06, 2020	BUY	$20.05 - $33.89 $4,471 - $7,557	223 Added 571.79%	262 $9,000
Q1 2020 Apr 13, 2020	BUY	$17.15 - $25.22 $668 - $983	39 New	39 $1,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.